Patents are the protected form of innovations and the currency of a knowledge-based economy. This article is an outcome of the analysis of working of patents data, which were published on the Indian Patent Office (IPO) website during 2012 and 2013, and continuously updated thereafter. For an overview of working of patents in India, an aggregate of 64 companies and/or organizations were selected for this study. The results of the analysis revealed that Qualcomm topped the list with 1113 granted patents at IPO, followed by Council of Scientific and Industrial Research (1085), Hindustan Unilever (773), Samsung Electronics (705), and Philips (352). The objective of this study was to determine the workability of patents in India, and the results indicated that all the seven patents granted to Indofil (an Indian company, which manufacturers agricultural, specialty and performance chemicals) were in working conditions, which apparently signified that the firm had effectively transferred the innovations for production and for the end-user. IPO was preferred as an important patent filling offices (PFO) by different national and international companies for filling their innovations. The results of this study provide an opportunity for the inventors, market players, researchers and consumers to know about the innovations which are lying in the PFOs of the different countries and lapsed after completing their life, i.e. 20 years.
'INNOVATION' is an important word, which is frequently used in today's academia and policy matters 1 . The Association of University Technology Managers (AUTM), USA, has defined it as 'the process of transferring scientific findings from one organization to another for the purpose of further development and commercialization' 2 . To define this word, Baregheh et al. 3 analysed 60 different definitions of innovation and concluded that 'Innovation is the multi-stage process whereby organizations transform ideas into new or improved products, services or processes, in order to advance, compete and differentiate themselves successfully in their marketplace'. It is an accepted fact that innovations emerge from the university system and are adopted by industry 4 . In USA, the research and development (R&D) organizations were reported to effectively transfer their intellectual property (IP)-protected technologies after 1980s, when the initial Bayh-Dole legislation was passed 5 . After this Act, the process of technology transfer became the responsibility of these institutions which got central funding 6 . Asia has been a prominent player not only in science, technology and innovation, but also in linking different cultures of the world 7 . An active academic technology transfer programme provides support and benefits to the public 8 .
Patents are the protected form of innovations and the currency of a knowledge-based economy. They are considered as an emerging asset that can be proactively managed, developed and nurtured to enhance business value 9, 10 . The patent system places innovations in a market process, acting simultaneously as a legal framework that facilitates disputes over ownership and infringement, thus lowering the cost of patent enforcement for individual firms 11 . Without a functioning or working patent system, knowledge and labour cannot be alienated, and its value would be limited to the ability or inclination of the innovator to put it to use 11 . Such a closed knowledge system would be disadvantageous for the innovators by inhibiting their ability to monetize their ideas, which they can do under a patent system even if they lack the time, skills or resources to commercialize it themselves 11 .
India is gifted with all the elements, which are necessarily required to become a global driver of innovation. It has a strong market potential, an innovative talent pool and an underlying culture of frugal innovation. Innovative countries have demonstrated the leverage of their cultural advantage to capture the potential markets in the world. For example, Japan leveraged its cultural emphasis on 'efficiency and team work' 12 , to revolutionize the manufacturing and engineering industries. The Republic of Korea (South Korea) utilized its cultural emphasis on 'speed' and it harbours the major world-class companies such as Samsung and LG. China has sustained a GDP growth in excess of 10% for more than two decades by virtue of its 'ability to scale'. USA and Israel have leveraged the diversity of their populations to lead global innovation.
An often-cited example of a US company leveraging global talent is that of General Electric (GE). GE has been an early pioneer of globalizing research with its centres in India, China, Germany and Brazil, in addition to the parent research centre in USA. The John F. Welch Technology Centre (JFWTC), in Bengaluru, India, was set up in September 2000 at its present 50-acre campus. Today, JFWTC is home to over 4000 researchers and engineers contributing to product development and IP filed and owned by the parent GE. Close to 2000 of the 30,000 patents awarded between 2011 and 2016 to GE have Indian inventors from JFWTC and Indian talent in other global centres 13 .
The performance of firms should not be measured based on the intensity of R&D expenditure, but on technology commercialization capabilities, which play the role of a mediator in the relationship between R&D and innovation performance 14 .
Statement of the problem
Intellectual Property Right (IPR) is a creation of the human mind 15 . From a social perspective, the absence of a functioning patent system as observed in many developing countries annihilates immeasurable values of knowledge and ideas by providing no system through which they could realize their tradable worth 11 . The actual growth of Science & Technology (S&T) in a country depends upon the working of the patents rather than the number of patents granted in that country. In view of the above, it has emerged that the status of local working of patents is of utmost importance to decipher the reach of innovation to its destination, i.e. user market. The Indian Patent Office (IPO) was selected for this purpose, where information received from patentees regarding working of patented inventions on a commercial scale (in India u/s 146 of the patents act 1970 for year 2012/2013) is published. Thus, the objective of this study was to know the status of local working of patents granted by IPO to different national and international organizations.
Materials and methods

Background
This article is an outcome of the analysis of working of patents data, which were published on the IPO website during 2012 and 2013, and continuously updated thereafter. The objective of this study was to determine the patent filing trends and their workability in India. A review of last 10 years' IPO annual reports indicates that the patent filing organizations at IPO belonged to different national as well as international public and private organizations 16 . For an overview of the working of patents in India, different types of literature, websites and research reviews were analysed, and finally 64 companies/organizations were selected for the study, which had also filed their patents at IPO. These companies/organizations belonged to different product/process/research subject domains, viz. agriculture, biotechnology, communication technology, engineering solutions, food processing, motor parts, pharmaceuticals, patent services, etc. Most of the selected companies are multinationals and a leading brand in their product range. To emphasize on the applicants from India, leading Indian group companies, and government-funded R&D organizations were also selected for this study. The patent data have been downloaded from the IPO website (data were accessed from the website during September to December 2016) and analysed according to patent filing and year of expiry, applicant organizations, working and non-working of patents, and their legal status at the IPO. The data had 40.73% duplication of information, which was removed after rigorous scrutiny of patent details. To know the worldwide IP portfolio of these companies/organizations with their legal status, Questel Orbit software was used (data were assessed during September 2016 and revised in March-April 2017), where data pertaining to only 57 companies/organizations were available. These data were analysed and presented in different heads, viz. granted, pending, revoked (a patent can be revoked on petition of any person interested or of the Central Government or on a counter claim in a suit for infringement of the patent by the High Court in India), expired (normally, a patent has a life of 20 years from filing; even when issued, a patent may expire early for a number of reasons) and lapsed (expired because maintenance fee was not paid on-time). The collected information was synthesized and compared with the different available databases, IP parameters, and paid and free search engines.
Theoretical orientation
Innovations are the building blocks of technological advancement, industrial development and economic welfare; which is possible through local working of inventions. The actual growth of S&T in a country depends upon the working of the patents rather than the number of patents granted in that country. Historically, patents were granted with an intention to encourage local application of the invention, through its industrial application.
An IP agreement is a written and enforceable contract that consummates and formalizes an agreement between two companies for the purchase and sale of IPRs 17 . IPRs are largely territorial rights, except copyright, which is global in nature in the sense that it is immediately available to all the members of the Berne Convention 18 . Patent is the strongest right among available IP tools, which gives exclusive right to the inventor for production, sale or use of the innovation in its stipulated time period, i.e. 20 years. It should be used to introduce new technology into the country for which the patent system has emerged.
Local working requirement and compulsory licenses enable the countries granting patents to force the foreign patentees to transfer technologies to their country. As a primary requirement, local working of patents has been the most efficient way of transfer of technology, although it has been noticed that these patents did not necessarily work locally 19 .
Local working of a patent is also known as commercial working of a patent in a country. It was first discussed in the Paris Convention, and Article 5(A), which deals with the working of patents and grant of compulsory licenses. It provides that importation of the patented articles should not result in forfeiture of the patent. This provision is similar to Article 27(1) of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement. It refers to the condition imposed on patentees or licensees that the patented product or process must be used or produced in the patent-granting country.
Article 27(1) of TRIPS states that the 'patents shall be available and patent rights enjoyable without any discrimination as to the place of invention, the field of technology and whether products are imported or locally produced' 20 . Article 7 of TRIPS states that the 'protection and enforcement of IPRs should result in technological innovation and its transfer' 21 . Notably, Article 8(1) allows the member countries to promote public interest in sectors of vital importance to their socio-economic and technological development, e.g. food, health, biotechnology, etc. 22,23 . It is noteworthy that the member states are free to define what they understand by 'failure to work'.
The Indian Patents Act 1970, imposes an obligation on the patentees and patent licensees to disclose information relating to the working of their patents in India; and has made it mandatory for all the patentees or patent licensees to submit information regarding commercial working of their patents in India. The term 'working' or 'local working' has not been defined under the Act. However, Sections 83(a), 83(b) and 85 refer to the working of patents in India. The working of patents falls under Section 146 of the Indian Patents Act, which authorizes the Controller General (CG) to call for information or periodical statement regarding the extent to which the patented invention has been commercially working in India from a patentee or patent licensee.
The patentee or patent licensee is required to furnish such information to the CG within two months from the date of such notice or such further period as the CG may allow. This information should be submitted in Form-27 in respect of every calendar year within three months of the end of each year. Form-27 comprises the following heads:
• Whether the invention has been working.
• If not working, the reasons for the same, and the steps being taken to work the invention.
• If working, quantum and value (in rupees) of the patented product: manufactured in India, imported from other countries, giving details of the countries concerned.
• Licenses and sub-licenses granted during the year.
• Whether the public requirement has been met, at a reasonable price, either partly, adequately or to the fullest extent.
Section 84(1) of the Patents Act, 1970 enlists the various circumstances which constitute 'failure to meet the reasonable requirements', of the public in respect of a patent 24 . The provision relating to local working has been incorporated with the wide objective of socio-economic welfare, i.e. to ensure the transfer of technology leading to industrial progress in addition to availability and affordability of patented goods. Such provision is more effective, particularly in the developing countries such as India, China, Brazil, etc. having a strong industrial set-up with the capacity to produce quality products at a cheaper rate. Prior to 2007, there was no study about local working of patented inventions in the annual reports of the Controller of Patents 25 .
Result and discussions
Worldwide IP filing trends A total of 2.9 million patent applications were filed worldwide during 2015, which recorded a growth of 7.8% compared to those filed during 2014. About 10.6 million patents were recorded to be in force during 2015. India ranked 21st among different countries and recorded 47,000 patents in force in its jurisdiction. The four BRIC countries -Brazil, Russia, India and China, ranked among the top 10 patent filing offices (PFOs). The United States Patent and Trademark Office (USPTO) recorded 2.64 million patents (24.9% of the world total), followed by 18.3% at Japan Patent Office (JPO) in 2015. Panasonic of Japan was the top applicant worldwide, followed by Japanese companies Canon (29,036) and Toyota Jidosha (26,844), and Samsung Electronics (26,647) of the Republic of Korea. China was the leading country in patents, trademarks and designs in IP filing ranking (resident and abroad) during 2015, followed by USA and the Republic of Korea (only in designs); whereas India ranked 14th in patents, sixth in trademarks and 13th in designs. Notably, India ranked tenth in patents, sixth in trademarks and 11th in designs by origin during 2015 (ref. 1).
IP filing trend at the IPO
The IPO witnessed 4.40% growth in overall filing of IP applications during 2014-2015 (262,638) compared to that recorded during 2013-2014. The disposal of patent applications at the IPO increased by 25.5%, which led to the grant of 5978 patent applications; registered 7147 On the basis of the above subject areas and their relevance to other (on-line and offline) available literature, the collected datasets of 8944 granted patents were classified in the following ten subheads with their number of organizations: Agri-research companies (991/9), biotech organizations (136/4), communication technology companies (3519/11), engineering solutions companies (195/3), food processing companies (52/2), Indian group companies (1184/5), Indian R&D organizations (1497/13), motor companies (403/3), patent service providers (316/1), and pharmaceutical companies (651/13) ( Figure 1 ). Communication technology companies topped the list with regard to granted as well as working and non-working patents (1927/1592). Figure 2 shows the working set of 64 organizations for their share in securing innovations by grant of patents and their actual use by licensing or working.
Patent filing trends and their working status
According to the subject area, a total of 64 selected patentees were classified in the following 10 broad categories:
Agri-research companies: This group is mostly comprised of nine seed, pesticide and farm machinery-based multinational companies, except Excel and Indofil (which are Indian pesticide companies). These companies filed 991 (15 (1991-1995) , 173 (1996) (1997) (1998) (1999) (2000) , 565 (2001) (2002) (2003) (2004) (2005) and 238 (2006-2010)) patent applications at the IPO from 1991 to 2010. These applications were granted and will be in force up to 20 years (after the date of filing). Among these 15 have already expired after the 20-year period, and the remaining 173 (2016-2020), 565 (2021-2025), 238 (2026-2030) are in force. Bayer (314) and BASF (313) were the leading companies that received the highest number of granted patents, followed by Syngenta (169), Du Pont (101) and Monsanto (44). Du Pont had licensed its 44 patents followed by Monsanto (41), BASF (40), Bayer (22) and Syngenta (19) , which have been instrumental in transferring their innovations in India. Indofil succeeded in licensing all its seven patents. This group had 11.08% share in total granted patents; 5.89% in the working of patents, and 13.74% in the non-working of patents. Table 2 indicates that most of working patents of this group are in force at the IPO.
Biotech companies: Four biotechnological research product-based companies were included in the working dataset belonging to Biotech companies. These companies filed a total of 136 patent applications (3 (1991-1995) , 29 (1996-2000) , 62 (2001) (2002) (2003) (2004) (2005) and 42 (2006-2010)) at the IPO from 1991 to 2010. Among these, three had expired after the 20-year period, whereas the remaining (29 (2016-2020), 62 (2021-2025), 42 (2026-2030)) are in force. Novozyme (a Denmark-based company) received grant for 85 patents from the IPO, followed by Biocon (31), Panacea and Serum (10 each). Notably, Novozyme also succeeded in licensing of all its 85 patents. This group had 1.52% share in total granted patents; 3.98% in the working of patents and 0.25% in the non-working of patents. Table 2 indicates fact that most of working patents of this group are in force at the IPO.
Communication technology companies:
This group is constituted by 13 multinational companies, which have a range of products in Indian communication technology market, viz. mobile phones, music systems, televisions, computers, software, etc. These companies filed a total of 3519 (56 (1991-1995) , 509 (1996-2000), 1927 (2001-2005) and 1027 (2006-2010)) patent applications at the IPO from 1991 to 2010. These applications were granted and will be in force up to 20 years (after the date of filing). Among these, 56 have already expired after the 20year period; whereas the remaining 3463 patents are in force. Qualcomm Inc., a world leader in 3G and nextgeneration mobile technologies 26 , had the highest of number of granted patents (1113), followed by Samsung Group (705), Koninklijke Philips Electronics (352) and Telefonaktiebolaget Lm Ericsson (299). Qualcomm Inc had succeeded in the licensing of its 1111 patents, followed by Nokia (154) and Koninklijke Philips Electronics (130). This group had 39.38% share in total granted patents; 52.42% in the working of patents, and 32.62% in the non-working of patents. Table 2 indicates that most of working patents of this group are in force at the IPO. Pharmaceutical companies: The past two decades witnessed the revolution in patenting and licensing in the Indian pharmaceutical sector. There has been significant development in this field due to greater demand for generic drugs in the developed countries, patent expiry and the growing importance of biologics. There has been a decline globally in the demand for patented and branded drugs due to the growing importance of generic drugs. In 2010, the share of patented drugs was 70% in the global market and it declined to 53% in 2015. A total of 67,342 patents were granted in India during 2006-2015, among which 56,727 were foreign and 10,615 were Indian inventors 34 . This group is a cluster of 13 major drug researchbased companies, comprising national as well as international giants of the pharmaceutical field. The group is led by Novartis, which is a global healthcare company based in Switzerland (it has a branch at Hyderabad, India) that provides solutions to address the evolving needs of patients worldwide 35 . Novartis received 149 patents from the IPO, followed by Cadila Healthcare (116; fourth largest pharmaceutical company in India; http://zyduscadila. com/) and Pfizer (82; an American global pharmaceutical corporation and among the world's largest pharmaceutical companies) 36 . These companies filed a total of 651 (8 (1991-1995) , 93 (1996) (1997) (1998) (1999) (2000) , 392 (2001-2005) and 158 (2006-2010)) patent applications at the IPO from 1991 to 2010. These applications were granted and will be in force up to 20 years (after the date of filing). Among these, eight patents have already expired after the 20-year period, and the remaining 643 patents will be in force. Aurobindo Pharma Limited is an Indian pharmaceutical company, which manufactures generic pharmaceuticals and active pharmaceutical ingredients 37 . The company transferred all of its patented innovations, followed by CIPLA (89.06%), Glenmark (87.50%) and Sunpharma (70%). This group had 7.27% share in total granted patents; 7.54% in the working of patents and 7.14% in the non-working of patents. Table 2 indicates that 643 of the working patents of this group are in force at the IPO.
Legal status of patents
Legal status of working of patents at IPO: The legal status of the total 8944 patents, which were granted to 64 organizations was analysed from the IPO website. It revealed that 69.85% of the total patents are in force, 21.33% were ceased, and 5.63% patents were lapsed owing to expiry after 20 years. As shown in Table 3 , working patents are more in force (80.92%), rather than non-working patents (63.98%); 26.02% non-working and Legal status of patents filed at different PFOs: Out of these 64 organizations, 57 had filed their innovations at different PFOs, including the IPO, viz. EPO, JPO, KPO, SIPO, USPTO, etc. To know the patent portfolio of these organizations with their legal status at different PFOs, data were collected from Questel Orbit (a paid search engine) and analysed accordingly. Table 4 shows the portfolios and their legal status.
Agri-research companies: Nine companies of this group filed 251,185 patent applications at different PFOs. Byer was the leading company with 73,433 patent applications; followed by Du Pont (69,279) and BASF (66,374). The legal status of these patents showed that 51.57% of the granted patents were expired (due to completion of patent life span, i.e. 20 years), 20.73% patents were lapsed because of non-payment of maintenance fee on time and 16.36% granted patents were in force; the remaining applications were revoked (6.37%), pending (4.80%) and some were not known due to different administrative or technical reasons (0.17%). These companies filed their 89.66% innovations as single applicant/assignee, and the remaining were in collaboration with other companies/ organizations.
Biotech companies: Only one company, viz. Panacea had filed 366 patent applications at different PFOs, of which 127 patents were in force and 119 were in process at different stages of grant. The remaining patents were lapsed (82), expired (28) and revoked (10) due to different technical reasons. Panacea had filed its 91.80% applications as the lead assignee. were pending at different PFOs, 19.98% patents were expired (due to completion of patent life span) and 17.27% patent applications were lapsed because of nonpayment of maintenance fee on time. The remaining applications were revoked (3.66%) and some were not known due to different administrative or technical reasons (0.11%). These companies filed their 88.56% patent applications as single applicant/assignee and the remaining were in collaboration with other companies/organizations.
Indian R&D organizations: This group comprised of 11
Indian government-funded educational, scientific and product-specific organizations, which had filed 14,849 patent applications at different PFOs. CSIR was the leading organization with 9809 patent applications followed by the IITs (2131), SAIL (601) and ICAR (536). The combined legal status of this group showed that 35.77% granted patents were in force, whereas 31.29% patent applications were pending at different PFOs, 20.83% patents were expired (due to completion of patent life span), and 11.17% patent applications were lapsed because of non-payment of maintenance fee on time. The remaining applications were revoked (0.68%) and some were not known due to different administrative or technical reasons (0.26%). These companies filed their 91.21% patent applications as single applicant/assignee, and the remaining were in collaboration with other companies/organizations.
Motor companies:
Three companies of this group filed 148,446 patent applications at different PFOs. Honda Motors was the leading company with 87,114 patent applications, followed by GM (60,206) and TVS (1126). The combined legal status of this group showed that 30.65% granted patents were in force, whereas 28.54% patents were expired (due to completion of patent life span) and 26.49% patent applications were lapsed because of non-payment of maintenance fee on time. The remaining applications were pending (10.67%) at different PFOs; revoked (3.62%) and some were not known due to different administrative or technical reasons (0.03%). These companies filed their 98.80% patent applications as single applicant/assignee and the remaining were in collaboration with other companies/organizations.
Patent service providers:
Only one company, viz. Thomson Reuters filed 374 patent applications at different PFOs, of which 230 patent were in force and 109 patent applications were in process at different stages of grant. Remaining patents were either lapsed (20) or expired (15) . Thomson Reuters had filed its 85.83% applications as the lead assignee.
Pharmaceutical companies: This cluster of 12 companies filed 63,935 patent applications at different PFOs. Pfizer (24, 286) , Novartis (19, 653) and Abott (14, 064) were the leading patent filing organizations in this group.
The combined legal status of this group showed that 37.24% granted patents were expired (due to completion of patent life span), 23.84% patents were lapsed due to non-payment of maintenance fee on time and 23.44% granted patents were in force. Remaining applications were pending (9.35%), revoked (5.73%) and some were not known owing to different administrative or technical reasons (5.84%). These companies filed their 85.95% patent applications as single applicant/assignee and the remaining were in collaboration with other companies/ organizations.
Conclusion
The objective of this study was to determine the workability of patents in India, and the results indicate that all the seven patents granted to Indofil were in working condition, which apparently signified that the firm had effectively transferred the innovations for production and for the end-user. Qualcomm (99.82%), CIPLA (89.06%), Glenmark (87.50%), Kirloskar (84.62%) and ISRO (83.67%) were also reported to adopt progressive efforts in workability of their patents at the IPO. The patent portfolio of these companies/organizations at different PFOs provided us with a broader knowledge with regard to the patents filed by the various organizations, Panasonic topped the list with 593,674 applications, followed by Samsung Electronics (271,195), Sony (203,609), LG Electronics (173,415), and General Electric (137,207). The legal status of this patent portfolio also showed that Panasonic had 45,813 patent applications pending at different PFOs, followed by Samsung Electronics (28,668), Robert Bosch (21,975), Sony (15, 772) and LG Electronics (14, 799) . Due to nonpayment or various irregularities in the maintenance of patent applications, PFOs have been empowered (the regulations are different in various countries) to revoke the patents. In this line, 35,081 applications of Panasonic
